SciELO - Scientific Electronic Library Online

 
vol.39 issue1Iron homeostasis in the lungCop-like operon: Structure and organization in species of the Lactobacillale order author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Biological Research

Print version ISSN 0716-9760

Biol. Res. vol.39 no.1 Santiago  2006

http://dx.doi.org/10.4067/S0716-97602006000100009 

 

Biol Res 39: 79-85, 2006

ARTICLE

DMT1: Which metals does it transport?

MICHAEL D GARRICK1,2, STEVEN T SINGLETON1, FARIDA VARGAS1, H-C KUO*1, LIN ZHAO1, MARTIN KNÖPFEL3, TODD DAVIDSON4, MAX COSTA4, PRASAD PARADKAR5, JEROME A ROTH5 and LAURA M GARRICK1,6

Departments of 1Biochemistry, 2Pediatrics, 5Pharmacology & Toxicology and 6Medicine, SUNY at Buffalo, Buffalo, NY, USA
3Tracechem, Berne, Switzerland
4Nelson Institute of Environmental Medicine, New York University, Tuxedo, NY, USA

Dirección para Correspondencia


ABSTRACT

DMT1 _ Divalent Metal (Ion) Transporter 1 or SLC11A2/DCT1/Nramp2 _ transports Fe2+ into the duodenum and out of the endosome during the transferrin cycle. DMT1 also is important in non-transferrin bound iron uptake. It plays similar roles in Mn2+ trafficking. Voltage clamping showed that six other metals evoked currents, but it is unclear if these metals are substrates for DMT1. This report summarizes progress on which metals DMT1 transports, focusing on results from the authors' labs. We recently cloned 1A/+IRE and 2/-IRE DMT1 isoforms to generate HEK293 cell lines that express them in a tetracycline-inducible fashion, then compared induced expression to uninduced expression and to endogenous DMT1 expression. Induced expression increases ~50x over endogenous expression and ~10x over uninduced levels. Fe2+, Mn2+, Ni2+ and Cu1+ or Cu2+ are transported. We also explored competition between metal ions using this system because incorporation essentially represents DMT1 transport and find this order for transport affinity: Mn>?Cd>?Fe>Pb~Co~Ni>Zn. The effects of decreased DMT1 also could be examined. The Belgrade rat has diminished DMT1 function and thus provides ways of testing. A series of DNA constructs that generate siRNAs specific for DMT1 or certain DMT1 isoforms yield another way to test DMT1-based transport.

Key terms: Metal ion transport; DCT1, Nramp2 or SLC11A2; expression assay: competition between metal ions


 

INTRODUCTION

DMT1 _ Divalent Metal (Ion) Transporter 1 or SLC11A2 (OMIM's designation for solute carrier family 11 member 2) / DCT1 (Divalent Cation Transporter 1) / Nramp2 (Natural resistance associated macrophage protein 2) _ definitely transports Fe2+ as part of both nutritional acquisition in the duodenum and exit from the endosome during the transferrin cycle (for reviews, see Garrick et al., 2003, and Garrick and Garrick, 2004). In addition to these two functions, DMT1 is likely to be important in non-transferrin bound iron uptake. The transporter probably plays similar roles in Mn2+ trafficking (for a review, see Roth and Garrick, 2003). Data from two-electrode voltage clamping studies (Gunshin et al., 1997) showed that six other metals evoked currents, but it is not clear if these metals are substrates for DMT1.

Five of these metals are essential micronutrients that are harmful in oversupply: Fe, Mn, Cu, Zn and Co. Hence it is desirable to know DMT1's role in their homeostasis. The other three, Ni, Cd and Pb, are toxic without any known countervailing benefit, so it would be useful to know if uptake by DMT1 contributes to their effects. Also, as noted by Arredondo et al. (2003), ascorbate was present during the pioneering voltage clamping studies (Gunshin et al., 1997). It was necessary to have Fe2+ available, but some of the other cations studied also could be reduced.

This paper is a progress report on which metals DMT1 transports. It summarizes data primarily from the authors' laboratories but also from many other groups and presents some previously unpublished data. At least four isoforms of DMT1 exist: 1A/+IRE, 1A/-IRE, 2/+IRE and 2/-IRE. In rats, all four share 543 central amino acid residues, but the N-terminus for those encoded by mRNA that starts with exon 1A has a 31 residue extension while the N-terminus starts in exon 2 for those encoded by mRNA that starts with exon 1B. C-terminal isoforms differ in the distal 18 or 25 amino acid residues. Because the mRNA isoforms that encode them differ by the presence or absence of an IRE (Iron Responsive Element) in the 3' UTR, the C-terminal isoforms are designated as ±IRE.

One might imagine that different isoforms exhibit a preference for different metal ions, so it would be beneficial to have a means of examining this possibility. Increasing or decreasing the expression of DMT1 species presents a way to do so. We (Kuo et al., 2004) have cloned the 1A/+IRE and 2/-IRE forms into the Gateway system (Invitrogen) and created HEK293 cell lines (Garrick et al., 2005, unpublished data) that express them in a tetracycline (or doxycycline) inducible fashion. We have compared induced expression to uninduced expression and to endogenous DMT1 expression by control cells with the empty vector or just with the system that renders the cells inducible. Induced expression increases ~50x over endogenous expression and ~10x over uninduced levels. This series of cell lines allows us to investigate which metals can be transported by DMT1.

Garrick et al. (2005, unpublished data) demonstrated that both isoforms transport Fe2+ and Mn2+. Chen et al. (2005) showed that the 2/-IRE species transports Ni2+; while Davidson, Vargas, Singleton, Garrick and Costa (unpublished data) have similar results for the 1A/+IRE species. Arredondo et al. (2005, unpublished data) examined Cu2+ and Cu1+ with HEK293 cells expressing the 2/-IRE form. Their data favor the hypotheses that Cu1+ is the ionic species taken up and that a reductase converts Cu2+ to that species before uptake; however, the data do not exclude the possibility that Cu2+ is a substrate for DMT1 with a lower affinity than Cu1+.

It is also easy to inquire into competition between metal ions using this system because incorporation essentially represents DMT1 transport without contributions from other transporters. Experimental results in this report come from this approach.

The ability to transport a metal ion in this assay is not an assurance that metal ion uptake normally relies on DMT1 because alternative pathways may be responsible for most transport. One can examine mutants like the Belgrade rat (Fleming et al., 1998) or the microcytic mouse (Fleming et al., 1997), both of which have a glycine to arginine mutation at the same residue. If one examines the protein isoforms starting in exon 2, the residue number is 185, therefore G185R in the original reports. Awareness of 1A isoforms now means that these should be called G216R in the rat or G215R in the mouse because there are 31 or 30 additional N-terminal residues, respectively. In the discussion below, we summarize some recent results from studies of the Belgrade rat; we are unaware of any recent results in the mouse model after our prior review (Garrick et al., 2003).

We also have developed a series of DNA constructs (SECs) that generate siRNAs specific for DMT1 or certain DMT1 isoforms. Formally, this approach is similar to the antisense technology used by Arredondo et al. (2003) to indict DMT1 in transport of Fe2+ and Cu1+ in Caco-2 cells. Using siRNA producing SECs in the same inducible expression system, we have evaluated semiquantitatively the effect of the siRNAs on levels of specific DMT1 isoforms. After such preliminary data are accumulated, expression of the same siRNA constructs in cells where only endogenous expression of DMT1 occurs should be informative of which metals are actually transported.

METHODS

Most of the methods were described recently (Kuo et al., 2004). The competition assays relied on incubating HEK293 cells containing one of the following two constructs: mouse 2/-IRE or rat 1A/+IRE (each with a strong cytomegalovirus promoter under tetracycline control and a tetracycline response element) in the presence or absence of 50 nM doxycycline for 24 hr. DMT1 expression (detected by uptake of Fe2+ or Mn2+) was ~50x endogenous levels after such induction or ~5x endogenous levels without such induction; hence uptake represented ≥98% or ≥80% DMT1 expression, respectively. When 59Fe2+ was the substrate, its concentration was 100 nM; for 54Mn2+ the concentration was 10 nM. Incubations were for 10 or 15 min in the presence of selected concentrations of competing metal ion, so that the initial velocity for uptake was measured. Statistical treatment of the data relied on linear regression analyses using Stata (StataCorp, College Station, TX). Additional details of the data reduction are described in the results to allow the reader to visualize how this was accomplished.

RESULTS

Competition between known substrates and candidates does not inform us as to whether the candidate is actually a substrate, but does reveal whether the candidate metal ion interacts with the transporter. An example is shown in figure 1, where Pb2+ (from lead acetate) inhibits Mn2+ uptake. Although there were four conditions for the incubations, the results could be combined to calculate an IC50 (Inhibitor Concentration that yields 50% of control) of 7.3 μM. It was desirable to have a quicker and less subjective method to get this value, so we relied on the observation that there appears to be a linear relation for the three series of percents over the concentration range 1-100 μM and calculated the IC50 by linear regression analysis, obtaining an estimate of 8.5 μM with R2 = 0.88. Similar calculations for an analysis of FeSO4 inhibition of Mn2+ uptake gave an estimate of 2.0 μM for that IC50 with R2 = 0.90 while the graphical estimate was 2.1 μM for the IC50. Linear regression analysis over the log/linear range therefore was applied to a series of analyses like figure 1 to get the data shown in table 1. The R2 ranged from 0.77 to 0.95 indicating that ~77 to ~95 % of the variation in the scatter is due to the linear relationship.

Figure 1. Inhibition of Mn uptake by Pb. Cells were incubated with 54Mn2+ and selected concentrations of lead acetate [Pb(CH3COO)2] with () and without () doxycycline for the 2/-IRE () and 1A/+IRE () lines. Although induced incorporation in the presence of doxycycline was ~10x that without induction, the incubations without Pb were treated as 100% uptake for each series to allow comparison. We fitted the concentration response with a single cubic spline because the 4 series of competitions were indistinguishable. Dropping a line from the 50 % level yielded an IC50 at 7.3 μM.

 

The data in table 1 indicate that there is generally satisfactory agreement between separate experiments when the same uptake is blocked by the same inhibitor, but there is a discrepancy when the uptake of Mn is compared to that for Fe. For examples, CoCl2 has similar IC50s of 87.6 and 80.2 when blocking 59Fe2+ uptake; but the IC50s of 8.3 and 6.4 when blocking 54Mn2+ uptake, although similar to each other, are more than 10x less. CdCl2 exhibits similar behavior but at a lower concentration. We consider the likely explanation in the discussion section that follows. The only exception to this observation is that ZnSO4 gives less reproducibility and that there is not so great a difference between its ability to block Fe and Mn uptake. These issues could relate to its being the least effective inhibitor. Although a number of metal ions remain to be studied, these data and data that show the Km to be ~1 mM for Mn2+ and ~3 mM for Fe2+ (Garrick et al., 2005, unpublished data) permit the following rankings for transport affinity of the metal ions: Mn2+>?Cd2+>?Fe2+ >Pb2+~Co2+~Ni2+ >Zn2+.

The data in table 1 favor the placement of Cd2+>Fe2+, but the question mark (?) is attached because the uncertainty in the IC50 measurements does not permit a stronger conclusion.

 

 

TABLE 1

Estimated IC50 for selected metal ions, inhibiting DMT1 metal ion uptake


IC50 by regression (μM)1
IC50 graphical (μM)2

Me2+ taken up

Inhibitor

2.0

2.1
54Mn2+ FeSO4

87.6

59Fe2+ CoCl2
80.2
59Fe2+ CoCl2
8.3
54Mn2+ CoCl2

6.4

54Mn2+ CoCl2

18.4

59Fe2+ CdCl2

21.3

59Fe2+ CdCl2

1.8

54Mn2+ CdCl2
0.5
54Mn2+ CdCl2

264.6

59Fe2+ ZnSO4

180.3

59Fe2+ ZnSO4

40.9

54Mn2+ ZnSO4

160.8

54Mn2+ ZnSO4

52.6

54Mn2+ ZnSO4
4.6
54Mn2+ Pb(C2H3O2)2

8.5

7.3
54Mn2+ Pb(C2H3O2)2
10.8
54Mn2+ NiCl2

5.5

54Mn2+ NiCl2

1 Each value estimated by linear regression analysis from three or more sets of points representing combined analyses on 2/-IRE and 1A/+IRE constructs with and without doxycycline as shown in figure 1 and described in the text. Combination of the points for linear regression analysis was justified by the lack of difference between constructs or for data with and without doxycycline. All represented 80% to 98% expression of the construct used because endogenous expression was 20% of that without doxycycline and 2% of that with doxycycline. Where there are pairs of values, each represents an independent experiment analyzed in this fashion.
2 Estimated graphically as shown in figure 1.

 

DISCUSSION

Competition

It was initially puzzling that the IC50 for CdCl2 was lower when it competed with Mn than when it competed with Fe and that a similar relationship occurred for CoCl2. One expected the Ki for DMT1 to be the same with CdCl2, independent of the substrate transported. An IC50 is not,however, a Ki. Their relationship was defined by Cheng and Prusoff (1973) as shown below in Equation 1.

 

 
IC50
(1) Ki =
  1 + [L] / KD

where [L] is the substrate (ligand) concentration and KD is the dissociation constant.

The arrangement in Equation 2 below aids us in viewing the influence of these variables.

  Ki * ( KD+ [L]

(2) IC50 =


 
KD

Although the KDs for Fe and Mn are unknown, the Kms are ~3 and ~1 μM (Garrick et al., 2005, unpublished data). If the ratios of the KDs is similar, and the KD for each is < [L], then the ratio of the substrate concentrations will affect the relative IC50 values. The ~10x difference that we see reflects the ratio [Fe]/[Mn] (= 10) closely, so we suspect that the weights of [L] and different KDs account for our observation.

The Belgrade (b/b) rat

Because G185R mutated DMT1 is clearly defective, preparations from b/b rats provide an opportunity to learn more about the role of the transporter. Knöpfel et al. (2005b) used vesicles prepared from duodenal brush border membranes (BBM) to investigate how a calcein-based fluorescence quenching assay performed when the vesicles' DMT1 was defective. The assay had been developed earlier but used only on normal rabbit BBM. The results indicated that defective b/b DMT1 in BBM failed to transport Ni2+, Fe2+ and Mn2+, while BBM from +/b rats transported all three divalent metal ions successfully. The data therefore provided confirmation that b/b DMT1 is defective and evidence that normal DMT1 transports the three metal ions. Their observation that vesicles from +/b basolateral membranes (BLM) also had vigorous transport, while those from b/b BLM did not, is evidence that DMT1 also may serve functions in enterocytes at other locations than the apical surface.

Ni transport into +/b vesicles was considerably slower than Mn or Fe (Knöpfel et al., 2005b). Davidson, Vargas, Singleton, Garrick and Costa (unpublished data) also observe that Ni uptake in HEK293 cells over-expressing DMT1 is slower than Mn or Fe uptake.

In the earlier paper, Zn2+ also caused quenching in calcein-loaded rabbit BBM (Knöpfel et al. 2000). Because Zn2+ itself does not quench calcein fluorescence, the authors proposed that proton cotransport was responsible and provided evidence that vesicle pH is actually affected. The alternative that Zn2+ gates proton transport and is not actually transported remains to be disproved, however. Nelson (1999; Sacher et al., 2001) initially favored that possibility, but currently supports Zn transport by DMT1 (Nevo and Nelson, 2004).

Very recently, Knöpfel et al. (2005a) employed b/b and +/b BBMV to show that Cu also is transported by DMT1, but only when the DMT1 is not defective. They examined both Cu2+ and Cu1+ as substrate. Although they saw activity with each, they argue that the former is the actual substrate. Interestingly, as mentioned in the introduction, Arredondo et al. (2005, unpublished data), assayed for uptake of Cu2+ and Cu1+ during induced DMT1 expression and seeing activity with both, interpreted the results as favoring the latter as the actual substrate. Resolving this dispute is beyond the scope of this discussion, but because Cu2+ can be reduced by a reductase that might be dcytb (Knöpfel and Solioz, 2002), it will take exceptionally well-controlled experiments to provide a final answer to whether one or both forms of Cu is a substrate for DMT1.

Knöpfel et al. (2005a) also took advantage of the absence of DMT1 activity in b/b preparations in two ways. They demonstrated that Co2+ is a substrate of DMT1 and showed that vesicles from b/b BBM had another transporter for Cu that depended on ATP and had a higher transport affinity. Ni and Co also exhibited ATP-driven transport. Forbes and Gros (2003) have also shown by calcein quenching that DMT1 transports Co and Mn in cells expressing high levels of DMT1.

Current status

The issue of which metals DMT1 transports remains a topic for intensive investigation. This report suggests the following order for DMT1 transport affinities: Mn>?Cd>?Fe>Pb~Co~Ni>Zn with some uncertainty on where to place Cu. One should keep in mind, however, that binding to DMT1 is only one of many factors that will determine the ultimate physiological and toxicological effects. Other metal-binding proteins and targets will play downstream roles and each may have alternative transporters. Keeping these caveats in mind, some conclusions are outlined below.

Fe2+ is definitely a substrate in which there is no question that DMT1's role is physiologically significant. One would like to know what other pathways for iron entry into cells and exit from endosomes exist, their relative contributions and what species of iron they involve. The same conclusion applies to Mn2+, but even less is known about alternative pathways and their relative impact.

DMT1 clearly can transport Cu, but whether the ionic form is cuprous or cupric is less certain. Other transporters clearly exist for this metal's ion(s), and the physiological role for DMT1 is still uncertain. Co is clearly a substrate, but the physiological significance of this observation needs additional elaboration; Zn may be a substrate but also deserves more study. There are clearly alternative transporters for Zn which begs the question of whether DMT1 plays much of a role physiologically, given the high concentration of Zn2+ needed for the IC50 and the total serum concentration of Zn of ~12-17 μM.

DMT1-mediated uptake of Ni is probably toxicologically relevant, but here too, more data are desirable. Cd binds tightly to DMT1 and earlier studies (reviewed in Garrick et al., 2003) leave little doubt that DMT1 actually transports this metal. Such transport also is probably relevant toxicologically. Pb may be transported by DMT1 as well (also

reviewed in Garrick et al., 2003), but there are questions about whether DMT1 transport of Pb is relevant toxicologically. Finally, we should keep in mind that the list of eight metals is almost certainly incomplete; other metal ions should be tested and even negative results should be reported.

ACKNOWLEDGMENTS

The research results reported or described here received support from NIH grants # DK59794 (LMG), ES11127 (JAR), ES00260 (MC), ES10344 (MC), 808 T32-ES07324 (MC) and a grant FP-91641801-0 from the Environmental Protection Agency (TD) plus a grant from the National Research Initiative of the USDA Cooperative State Research, Education and Extension Service, 2001-35200-10723 (MDG).

REFERENCES

ARREDONDO M, MUÑOZ P, MURA CV, NÚÑEZ MT (2003) DMT1, a physiologically relevant apical Cu1+ transporter of intestinal cells. Am. J. Physiol. Cell Physiol. 284: C1525-C1530         [ Links ]

CHEN H, DAVIDSON T, SINGLETON S, GARRICK MD, COSTA M (2005) Nickel decreases cellular iron level and converts cytosolic aconitase to iron regulated protein 1. Toxicol. Appl. Pharmacol. 206: 275-287         [ Links ]

CHENG Y, PRUSOFF WH (1973) Relationship between the inhibition constant (Ki) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction. Biochem. Pharmacol. 22: 3099-3108         [ Links ]

FLEMING MD, TRENOR CI, SU MA, FOERNZLER D, BEIER DR, DIETRICH WF, ANDREWS NC (1997) Microcytic anaemia mice have a mutation in Nramp2, a candidate iron transporter gene. Nature Genet. 16: 383-386         [ Links ]

FLEMING MD, ROMANO MA, SU MA, GARRICK LM, GARRICK MD, ANDREWS NC (1998) Nramp2 is mutated in the anemic Belgrade (b) rat: Evidence of a role for Nramp2 in endosomal iron transport. Proc. Natl. Acad. Sci. USA 95: 1148-1153         [ Links ]

FORBES JR, GROS P (2003) Iron, manganese, and cobalt transport by Nramp1 (Slc11a1) and Nramp2 (Slc11a2) expressed at the plasma membrane. Blood 102: 1884-1892         [ Links ]

GARRICK MD, DOLAN KG, GHIO A, HORBINSKI C, HIGGINS D, PORUBCIN M, MOORE EG, HAINSWORTH LN, UMBREIT JN, CONRAD ME, FENG L, LIS A, ROTH JE, SINGLETON S, GARRICK LM (2003) DMT1 (Divalent Metal Transporter 1): A mammalian transporter for multiple metals. BioMetals 16: 41-54         [ Links ]

GARRICK MD, GARRICK LM (2004) Divalent metal transporter DMT1 (SLC11A2). In: BROER S, WAGNER C (eds) Membrane Transporter Diseases. Dordrecht: Kluwer, pp: 107-122         [ Links ]GARRICK MD, KUO H, VARGAS F, SINGLETON ST, ZHAO L, SMITH JJ, PARADKAR P, ROTH JA, GARRICK LM (2005) Comparison of mammalian cell lines expressing distinct isoforms of divalent metal transporter 1 in a tetracycline-regulated fashion. J. Biol. Chem. Ms submitted         [ Links ]

GUNSHIN H, MACKENZIE B, BERGER UV, GUNSHIN Y, ROMERO MF, BORON WF, NUSSBERGER S, GOLLAN JL, HEDIGER MA (1997) Cloning and characterization of a mammalian proton-coupled metal-ion transporter. Nature (London) 388: 482-488         [ Links ]

KNÖPFEL M, SCHULTHESS G, FUNK F, HAUSER H (2000) Characterization of an integral protein of the brush border membrane mediating the transport of divalent metal ions. Biophys. J. 79: 874-884         [ Links ]

KNÖPFEL M, SOLIOZ M (2002) Characterization of a cytochrome b558 ferric/cupric reductase from rabbit duodenal brush border membranes. Biochem. Biophys. Res. Commun. 291: 220-225         [ Links ]

KNÖPFEL M, SMITH C, SOLIOZ M (2005a) ATP-driven copper transport across the intestinal brush border membrane. Biochem. Biophys. Res. Commun. 330: 645-652         [ Links ] KNÖPFEL M, ZHAO L, GARRICK MD (2005b) Transport of divalent transition-metal ions is lost in small-intestinal tissues of b/b Belgrade rats. Biochem. 44: 3454-3465         [ Links ]

KUO HC, SMITH JJ, LIS A, ZHAO L, GONSIOREK EA, ZHOU X, HIGGINS DM, ROTH JA, GARRICK MD, GARRICK LM (2004) Computer-identified nuclear localization signal in exon 1A of the transporter DMT1 is essentially ineffective in nuclear targeting. J. Neurosci. Res. 76: 497-511         [ Links ]

NELSON N (1999) Metal ion transporters and homeostasis. EMBO J. 18: 4361-4371.         [ Links ]

NEVO Y, NELSON N (2004) The mutation F227I increases the coupling of metal ion transport in DCT1. J. Biol. Chem. 279: 53056-53061         [ Links ]

ROTH JA, GARRICK MD (2003) Iron interactions and other biological reactions mediating the physiological and toxic actions of manganese. Biochem Pharmacol 66: 1-13         [ Links ]

SACHER A, COHEN A., NELSON N (2001) Properties of the Mammalian and Yeast Metal-Ion transporters DCT1 and Smf1p Expressed in Xenopus laevis oocytes. J. Exp. Biol. 204: 1053-1061         [ Links ]

* Current address, Departments of Biochemistry, Duke University, Durhman, NC, USA.

Corresponding author: Michael D. Garrick, Department of Biochemistry, SUNY, 140 Farber Hall, Buffalo, NY 14214, USA, Tel.: (1-716) 829-3926, Fax: (1-716) 829-2725, E-mail: mgarrick@buffalo.edu

Received: April 4, 2005. Accepted: May 3, 2005.